AIM Breakfasts

AIM BREAKFAST – 9th August 2016

Set Menu AIM:

Total number of AIM Companies (Incl Susp): 1,008

Total number of AIM Companies trading: 992*
* As at 08 August 2016

Dish of the Day:

No Primary Today

Off the Menu:

No Leavers Today

Set Menu ISDX Growth:

Total number of ISDX Growth Market Companies (Incl Susp): *

Total number of ISDX Growth Market Companies trading: *
* As at 08 August 2016

Dish of the Day:

Off the Menu:

What’s Cooking in the IPO Kitchen?

LoopUp—The provider of conference calls and online meetings is seeking to join AIM. 2015 revs of £9.2m and EBITDA of £1.02m

Bacanora Lithium— To list on AIM as holding company for TSX listed Bacanora Minerals at £100m market cap

The Intertain Group Ltd – World’s largest online bingo-led operator (on TSX) intends to join Official List

Autins Group plc – The acoustic and thermal insulation specialist  looks to join AIM early August


Breakfast Buffet

OptiBiotix Health*(OPTI.L) 75.5p £58.9m

Great retail win announced by OptiBiotix today with its JV company’s GoFigure® meal replacement shakes and natural snack bars now available for sale in UK stores of the Whole Foods Market,  a large ($15bn turnover in 2015) American supermarket chain exclusively featuring healthy foods.  There are circa 9 stores in the  UK . We would hope that a good retail performance here could open the door stateside.  The products contain SlimBiome®, a patented weight management formulation.


Highland Gold Mining (HGM.L) 142.5p £463.4m

Q2 operating results.  Total Q2 2016 production of 71,782 oz of gold and gold equivalent at Mnogovershinnoye (MNV), Novoshirokinskoye (Novo) and Belaya Gora, up 12%.     Average realized gold price of 1,264 USD/oz over the reporting period.  Exploration work continued on the Northern ore body at MNV, with reserves expected to receive approval from regulators by year-end.  Work commenced on the planned expansion of processing capacity at the Novo mill.


Utilitywise (UTW.L) 126p £98.4m

The independent utility cost management consultancy, announces the appointment of Brendan Flattery as Chief Executive Officer, effective 1 October 2016. Brendan joins Utilitywise from The Sage Group plc (SGE.L), where, as President, Europe, he was responsible for leading a 7,000-person business unit operating across 11 countries which generated annual revenues of circa £800 million from a customer base of more than two million. Recent guidance for FY Jul 16. Rev > £82m. EBITDA > £17.8m.


Mkango Resources (MKA.L) 8c $5.3m

The explorer for rare earth elements and          associated minerals in the Republic of Malawi,  has announced the  results of the airborne geophysical survey covering approximately two thirds of its Phalombe licence. The Survey was part of a US$25 million World Bank funded nationwide airborne geophysical programme. The survey highlights a number of targets within  the licence area.


STM Group (STM.L) 32.5p £19.3m

The cross border financial services provider has provided a trading update. Following its decision to waive establishment  fees on its core QROPS pension product, July sales of the product saw a 28% increase over those of June, which was in turn a 15% increase over those of May. New business applications in July 2016 represent the highest month of applications over the last twelve months and a 75% uplift on the average number of applications received in the first four months of the year.  The FY2016E PE is 6.6x.


Aquatic Foods Group (AFG.L) 12p £13.6m

The Chinese marine foods and seafood processor and producer, supplying to export and local markets, has announced the appointment of Ms Po Ling Low as Finance Director. She has over 18 years of experience in the corporate finance, audit and investor relations sectors across the UK and Asia, and is a Chartered Certified Accountant. In 2008,  she became CFO of West China Cement Limited which had previously been listed on AIM before moving to a HK main board listing in 2010. 500k warrants awarded at 20-50p.


Motif Bio (MTFB.L) 63p £68.4m

The clinical stage biopharmaceutical company specialising in developing novel antibiotics, has announced that, as a result of market conditions, it has deferred pricing of its proposed public offering of American Depositary Shares (“ADSs”) and listing of ADSs on the NASDAQ Global Market; however, the Company intends to continue to engage with investors. The Company will provide an update to the market in due course.


Hargreaves Services (HSP.L) 193.25p £61.7m

Prelims to May 2016 from the company, specialised in sourcing, producing, processing, handling and transporting carbon-based and other bulk materials throughout the UK and Europe.  Operations have been greatly scaled back.   Underlying Operating Profit of £4.6m  vs £42.8m. There are £60m of legacy assets that Hargreaves aims to convert to cash.


GLI Finance (GLIF.L) 27.13p £77.2m

The investor  in the SME Alternative Finance sector  has announced a £7.1m underwritten placing at 31p, a 14.3% premium to yesterday’s close. The company has amended its dividend policy abandoning the 2.5p annualised minimum after the 2016 financial year. GLI continually reviews the returns earned from its investments, and in future may source further cash resources through the sale of more liquid assets which may not be providing adequate returns.


Faroe Petroleum (FPM.L) 67.5p £80.45m

The independent oil and gas company focusing principally on exploration, appraisal, development and production opportunities in Norway and the UK, announced on 21 July 2016 the proposal to issue 5,958,896 Open Offer Shares at an issue price of 70 pence.  As announced today, there has been a 13.7% take up of the underwritten offer which follows a recent £62m over subscribed placing.


Head Chef:

Derren Nathan
0203 764 2344

*A corporate client of Hybridan LLP


This document, which does not constitute research, has been issued by Hybridan LLP for information purposes only and should not be construed in any circumstances as an offer to sell or solicitation of any offer to buy any security or other financial instrument, nor shall it, or the fact of its distribution, form the basis of, or be relied upon in connection with, any contract relating to such action. This document has no regard for the specific investment objectives, financial situation or needs of any specific entity and is not a personal recommendation to anyone. Recipients should make their own investment decisions based upon their own financial objectives and financial resources and, if any doubt, should seek advice from an investment advisor.

The information contained in this document is based on materials and sources that are believed to be reliable; however, they have not been independently verified and are not guaranteed as being accurate. This document is not intended to be a complete statement or summary of any securities, markets, reports or developments referred to herein. No representation or warranty, either express or implied, is made or accepted by Hybridan LLP, its members, directors, officers, employees, agents or associated undertakings in relation to the accuracy, completeness or reliability of the information in this document nor should it be relied upon as such.

Any and all opinions expressed are current opinions as of the date appearing on this document only. Any and all opinions expressed are subject to change without notice and Hybridan LLP is under no obligation to update the information contained herein. To the fullest extent permitted by law, none of Hybridan LLP, its members, directors, officers, employees, agents or associated undertakings shall have any liability whatsoever for any direct or indirect or consequential loss or damage (including lost profits) arising in any way from use of all or any part of the information in this document.

This document should not be relied upon as being an independent or impartial view of the subject matter and, for the avoidance of doubt, does not constitute “independent investment research” for the purposes of the Financial Conduct Authority rules. The individuals who prepared this document may be involved in providing other financial services to the company or companies referenced in this document or to other companies who might be said to be competitors of the company or companies referenced in this document. As a result both Hybridan LLP and the individual members, directors, officers and/or employees who prepared this document may have responsibilities that conflict with the interests of the persons who receive this document. Hybridan LLP and/or connected persons may, from time to time, have positions in, make a market in and/or effect transactions in any investment or related investment mentioned herein and may provide financial services to the issuers of such investments.

In the UK, this document is directed at and is for distribution only to persons who (i) fall within Article 19(5) (persons who have professional experience in matters relating to investments) or Article 49(2) (a) to (d) (high net worth companies, unincorporated associations, etc) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (as amended) or (ii) are Professional Clients or Eligible Counterparties (as those terms are defined in the rules of the Financial Conduct Authority) of Hybridan LLP (all such persons referred to in (i) and (ii) together being referred to as “relevant persons”). This document must not be acted on or relied up on by persons who are not relevant persons. For the purposes of clarity, this document is not intended for and should not be relied upon by persons who would be classified as Retail Clients (as defined by the rules of the Financial Conduct Authority).

Neither this document nor any copy of part thereof may be distributed in any other jurisdictions where its distribution may be restricted by law and persons into whose possession this document comes should inform themselves about, and observe, any such restrictions. Distribution of this report in any such other jurisdictions may constitute a violation of UK or US securities law, or the law of any such other jurisdictions.

Hybridan LLP and/or its associated undertakings may from time-to-time provide investment advice or other services to, or solicit such business from, any of the companies referred to in this document. Accordingly, information may be available to Hybridan LLP that is not reflected in this material and Hybridan LLP may have acted upon or used the information prior to or immediately following its publication. In addition, Hybridan LLP, the members, directors, officers and/or employees thereof and/or any connected persons may have an interest in the securities, warrants, futures, options, derivatives or other financial instrument of any of the companies referred to in this document and may from time-to-time add or dispose of such interests.

Neither the whole nor any part of this document may be duplicated in any form or by any means. Neither should this document, or any part thereof, be redistributed or disclosed to anyone without the prior consent of Hybridan LLP.
Hybridan LLP is a limited liability partnership registered in England and Wales, registered number OC325178, and is authorised and regulated by the Financial Conduct Authority and is a member of the London Stock Exchange. Any reference to a partner in relation to Hybridan LLP is to a member of Hybridan LLP or an employee with equivalent standing and qualifications. A list of the members of Hybridan LLP is available for inspection at the registered office, 2 Jardine House, The Harrovian Business Village, Bessborough Road, Harrow, Middlesex HA1 3EX. If you would like to unsubscribe, please email with “unsubscribe me”.